Saundra Pelletier

Saundra Pelletier is the Chief Executive Officer, President, and Executive Director of Evofem Biosciences, a position she has held since February 2015.13 She is a dynamic leader in the biotech industry, focused on revolutionizing women's healthcare with innovative products.

Career Highlights

Pelletier has over 25 years of experience in the pharmaceutical industry.1 At Evofem Biosciences, she has been instrumental in:

• Leading the company's growth and transition to the public market in January 2018
• Raising over $500 million through multiple equity financing rounds
• Launching Phexxi, the first and only FDA-approved, non-hormonal, on-demand birth control24

Background and Education

Originally from Caribou, Maine, Pelletier attended the New England School of Communications.2 She later received an honorary degree from Husson University in 2022.2

Leadership and Advocacy

Pelletier is known for her advocacy in women's healthcare innovation. She has:

• Served as Executive Director at Woman Care Global, providing reproductive healthcare access in low- and middle-income countries
• Founded WCG Cares, a global non-profit delivering women's reproductive health products in over 100 countries2
• Appeared at various high-profile events, including TEDx San Diego and the Davos World Economic Forum1

Personal Challenges

In July 2018, Pelletier was diagnosed with late-stage breast cancer. She continued to lead Evofem while undergoing multiple surgeries and intensive chemotherapy.2

Current Focus

Pelletier is currently steering Evofem Biosciences through significant financial challenges. The company has faced delisting from Nasdaq and has had to make substantial staff cuts and salary reductions.5 Despite these obstacles, Pelletier remains committed to the company's mission of addressing unmet sexual and reproductive health needs of women.